comprehensive -WSS

comprehensive

author：fashion 2025-10-01 00:49:34 - browse：6825

RHONA WISE/AFP via Getty Images

WASHINGTON — Drugmakers are doing everything to tap the bottomless well of demand for new obesity drugs, and they might get some government help. The agency that regulates Obamacare insurance is considering a technical change that would require insurers to cover obesity drugs in a market of more than 20 million Americans.

Weight loss drugs are a blessing for patients, a boon for drugmakers, and a potentially huge expense for insurers and taxpayers. Insurers have been slow to cover the drugs, called GLP-1 agonists, and without insurance, it costs upward of $16,000 annually for a drug that must be taken indefinitely.

There is a lot of demand for the drugs, but there are barriers to coverage. Medicare by law is prohibited from paying for obesity drugs. State Medicaid programs don’t have to cover them, so most don’t.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： WuXi Biologics execs register to lobby as Congress comes for the company

WSS

Obesity drug from Roche shows promise in early study

Cancer drug shortages' outsize impact on ovarian cancer patients

ActiGraph execs on goal of drug approvals with digital endpoints

ActiGraph execs on goal of drug approvals with digital endpoints

Abbott's new stent may help patients with peripheral artery disease

Hilary expected to bring catastrophic, life

Wikipedia

comprehensive

hotspot

The high cost of giving birth even with insurance

Ukraine taking heavy casualties 10 weeks into its counteroffensive

Trump demands the U.S. pay no more for drugs than other countries … again

WuXi Biologics beefs up its lobbying operation

Duchenne breakthrough therapy leaves behind pioneering families

Clinical trials must include more disabled people

Trump demands the U.S. pay no more for drugs than other countries … again

Oak Street deal isn't the answer to health care's woes

In age of alternative facts, a scholarly course on calling out crap

Ripples from Flovent's discontinuation is killing children with asthma

leisure time

Evacuations in place as 3 wildfires burn in eastern Washington state

Galapagos to make CAR

Evacuations in place as 3 wildfires burn in eastern Washington state

Vaccine critic Robert F. Kennedy Jr. says he'll chair Trump vaccine panel

Beware the threat of staffing cuts at the CDC

Evacuations in place as 3 wildfires burn in eastern Washington state

hotspot

hotspot

entertainment

knowledge